Loading company…
SPMED develops precision medicine using genomic, clinical, environmental, and lifestyle information.
SPMED develops precision medicine based on genome, clinical, living environment, and habit information. Founded in 2016 by researchers with experience in drug genomics, the company is based in Busan, South Korea, and is led by Professor Jae-guk Shin of Inje University Hospital. It has worked with designated hospitals on pharmacogenetic testing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in